Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Industry News
Industry News
Systagenix Wound Management Introduced as a New Force in Wound Care
Systagenix Wound Management (London) is a new portfolio company created by One Equity Partners (New York, NY) that was recently launched with the intent of establishing a new global force in advanced wound care.
Industry News
Arobella Medical CEO issued US Patent for Ultrasound Technology
Arobella Medical LLC (Minneapolis, Minn) announced that its Co-founder, President and CEO Eliaz Babaev, PhD, was issued a US patent that covers technology employed in the next generation of the company’s Qoustic Wound Therapy System®.
Industry News October 2008
SAWC/WHS Survey Provides Insight Regarding Change in CMS Guidelines
DM Systems Inc (Evanston, Ill) recently released results from a survey conducted at the 2008 Symposium on Advanced Wound Care and Wound Healing Society Meeting (SAWC/WHS). A total of 153 professionals who visited the DM Systems booth completed the survey, which revealed how much the new CMS guidelines will change the way healthcare professionals think about and respond to heel pressure ulcers.
Industry News
RF Technologies® Help Healthcare Providers Avoid Preventable Injuries
RF Technologies® (Brookfield, Wis) is partnering with healthcare providers throughout the country in an effort to assist with compliance of the new Medicare regulations that go into effect October 1, 2008. The Centers for Medicare and Medicaid Services (CMS) placed a mandate that healthcare providers will not be eligible for reimbursement of expenses related to preventable hospital injuries. CMS will also bar providers from directly billing patients for expenses related to such injuries.
WOUNDS May
Stem Cell Research Foundation’s First Grant Awarded to John D. Gearhart
The Stem Cell Research Foundation (SCRF), a program of the American Cell Therapy Research Foundation, has awarded its first research grant to John D. Gearhart, PhD, of the Johns Hopkins School of Medicine in Baltimore, Maryland. The foundation was established in 2000 to help fund cutting-edge research in the new science. Dr. Gearhart and his coinvestigator, Michael J. Shamblott, PhD, also of Johns Hopkins, will be working with human pluripotent stem cells in an attempt to develop a hardier, more useful stem cell line
June 2008
Bristol-Myers Squibb Sells ConvaTec Business Unit
Bristol-Myers Squibb Company (New York, NY) has signed an agreement to sell its ConvaTec (Princeton, NJ) business unit to Nordic Capital Fund VII (Stockholm, Copenhagen, and Helsinki) and Avista Capital Partners (New York, NY and Houston, Tex) for $4.1 billion.
The transaction is subject to customary regulatory approvals and delivery of the company’s audited 2007 financial statements. The closing is anticipated to take place the third quarter of 2008.
July 2008
International Best Practices Introduced for V.A.C.® Therapy The first comprehensive publication of international best practices for the use of KCI’s V.A.C.® Therapy (KCI, San Antonio, Tex) was introduced at the Third Congress of the World Union of Wound Healing Societies in Toronto, Canada.
Entitled, Principles for Best Practice—Vacuum Assisted Closure: Recommendations for Use, A Consensus Document, the document was developed by an international expert working group to provide guidance on the successful integration of the V.A.C. into clinical practice for
April 2002
biolitec Clinical Study: Wound Healing by Laser Light
biolitec, Inc. is currently seeking investigators and subjects for a new clinical study to assess the efficacy of laser light at the 980 nm wavelength in healing all diabetic foot wounds. The selection process for qualified investigators is underway with the objective of establishing several study sites in the United States.
The study entails the application of laser light at the 980 nm wavelength—using the biolitec Ceralas D diode laser and a special collimating handpiece—to subjects’ wounds over the course of several weeks or
June
Incidence of Pressure Ulcers Reduced by up to 87 Percent Using Skin Care Prevention Systems According to Yale Clinical Study
Yale School of Nursing (YSN) researchers found that a comprehensive prevention program significantly reduced the incidence of pressure ulcers. In the clinical study, “A Comprehensive Program to Prevent Pressure Ulcers in Long Term Care: Exploring Costs and Outcomes,” the Yale School of Nursing investigators discovered that using specially formulated skin care products with Solutions‚ standardized protocols of care, reduced the incidence of pressure ulcers by up to
Industry News
KCI Enters into Agreement with 3M Health Care
Kinetic Concepts Inc (San Antonio, Tex) entered into an agreement with 3M Health Care (St. Paul, Minn) for the supply of 3M Tegaderm™ brand transparent film dressings for inclusion in KCI kits with KCI’s V.A.C.® Therapy System in the treatment of complex, hard-to-heal wounds. The newly designed Tegaderm dressing that was configured exclusively for use with V.A.C. Therapy will provide a skin-friendly interface that conforms to the body and flexes with skin for greater patient comfort.
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
